# A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects

> **NCT06762600** · PHASE1 · COMPLETED · sponsor: **Fujian Shengdi Pharmaceutical Co., Ltd.** · enrollment: 102 (actual)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** HRS-4729 injection
- **DRUG:** HRS-4729 injection placebo
- **DRUG:** HRS9531 injection
- **DRUG:** HRS9531 injection placebo
- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT06762600
- **Lead sponsor:** Fujian Shengdi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-16
- **Primary completion:** 2026-03-12
- **Final completion:** 2026-03-12
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06762600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06762600, "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06762600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*